AstraZeneca PLC is 123.0x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($286.27 B vs $2.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PBH | AZN |
|---|---|---|
| Market cap | $2.33 B | $286.27 B |
| US-listed rank | #1987 | #45 |
| Revenue (latest FY) | $1.09B | - |
| Net income (latest FY) | $190.30M | - |
| Net margin | 17.5% | - |
| P/E (trailing FY) | 12.2 | - |
| SEC filings | 1,235 | 1,004 |
AstraZeneca PLC is 123.0x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($286.27 B vs $2.33 B).
Full pages: Prestige Consumer Healthcare Inc. and AstraZeneca PLC, or browse the full rankings.